Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 44 Show results per page	View Search Criteria \| Help With Results

Last Modified: 8/28/2008 First Published: 7/1/2002


1.		A Phase III Randomized Double-Blind Study of Adjuvant Imatinib Mesylate (Gleevec; STI571) Versus Placebo in Patients Following the Resection of Primary Gastrointestinal Stromal Tumor (GIST)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				ACOSOG-Z9001 CAN-NCIC-SRC1, CALGB-ACOSOG-Z9001, SWOG-ACOSOG-Z9001, NCT00041197, UWCC-UW-6303, UWCC-UW-03-8438-A-03, SRC1

Last Modified: 6/13/2008 First Published: 6/23/2003


2.		Phase III Randomized Study of Dexamethasone With or Without Lenalidomide in Patients With Previously Untreated Stage I, II, or III Multiple Myeloma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				SWOG-S0232 S0232, NCT00064038

Last Modified: 5/7/2008 First Published: 12/23/2003


3.		Phase III Randomized Study of Valeriana officinalis (Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				18 and over				NCI				NCCTG-N01C5 N01C5, NCT00075842

Last Modified: 12/23/2008 First Published: 3/24/2004


4.		Phase III Randomized Study of Creatine in Patients With Cancer-Associated Weight Loss

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				18 and over				NCI				NCCTG-N02C4 NCT00081250, N02C4

Last Modified: 11/14/2008 First Published: 7/23/2004


5.		Phase III Randomized Study of Docetaxel With or Without Gefitinib in Patients With Metastatic or Locally Recurrent Squamous Cell Carcinoma of the Head and Neck

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				ECOG-E1302 E1302, NCT00088907

Last Modified: 10/21/2008 First Published: 7/23/2004


6.		Phase III Randomized Study of Prednisone and Cyclosporine or Tacrolimus With Versus Without Mycophenolate Mofetil in Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				4 and over				NCI				FHCRC-1697.00 5332, ROCHE-FHCRC-1697.00, NCT00089141, UMN-2004UC007

Last Modified: 10/29/2008 First Published: 8/24/2004


7.		Phase III Randomized Study of Levocarnitine (L-carnitine) for the Management of Fatigue in Cancer Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Completed				18 and over				NCI				ECOG-E4Z02 NCT00091169, E4Z02

Last Modified: 6/23/2008 First Published: 4/23/2005


8.		Phase III Randomized Study of Carboplatin and Paclitaxel With Versus Without Sorafenib in Patients With Unresectable Stage III or Stage IV Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				ECOG-E2603 E2603, NCT00110019

Last Modified: 5/22/2008 First Published: 4/23/2005


9.		Phase III Randomized Study of Docetaxel and Prednisone With Versus Without Bevacizumab in Patients With Hormone-Refractory Metastatic Adenocarcinoma of the Prostate

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				CALGB-90401 ECOG-90401, NCT00110214

Last Modified: 5/22/2008 First Published: 5/23/2005


10.		Phase III Randomized Study of Cytarabine With Versus Without VNP40101M in Patients With Acute Myeloid Leukemia in First Relapse

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Temporarily closed				18 and over				Pharmaceutical / Industry				VION-CLI-037 NCT00112554

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute